Paralysis Recovery Drug: Brazilian Injection Helps Man Walk Again

Brazilian researcher Tatiana Sampaio developed a paralysis recovery drug that may restore movement after spinal cord injury. The treatment uses a compound derived from placental laminin protein. It aims to rebuild damaged nerve connections inside the spinal cord. As a result, patients may regain lost mobility over time. The approach offers new hope for conditions once considered permanent. Scientists have worked on this idea for more than 25 years.

Pilot study results in Brazil

In a 2025 pilot study, researchers tested the injection on a quadriplegic man. He had lost movement after a car accident in 2018. After receiving a single injection, he slowly regained foot movement. Later, he was able to walk again with support. However, doctors continue to monitor his progress carefully.
The study suggests strong early potential. Therefore, researchers see it as a major step forward in spinal repair science. The participant’s recovery surprised many experts in the field. It also encouraged further investigation into similar treatments.

How the drug works

The drug, called polylaminin, forms a biological mesh in the injured spinal cord. This structure helps guide nerve fibers to grow new pathways. In addition, it improves communication between the brain and body. As a result, movement signals may travel again through repaired routes.
Animal trials in rats and dogs also showed improved motor function. Importantly, no major side effects were reported in early testing. However, scientists stress that more research is still needed.

Future of spinal repair

Full clinical trials are still awaiting regulatory approval in Brazil. Therefore, the treatment is not widely available yet. Experts believe larger studies will confirm safety and effectiveness. If successful, this therapy could change paralysis care worldwide. It may offer new independence to millions of patients. For now, the results bring cautious but powerful hope for the future of medicine.